Memantine agonist action at dopamine D2High receptors

Synapse

Volumn 62, Issue 2, 2008, Pages 149-153

  Seeman, Philip ^a   Caruso, Carla ^b   Lasaga, Mercedes ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

3H domperidone; Dopamine D2 receptor; Memantine; NMDA receptor; Prolactin

Indexed keywords

DOMPERIDONE; DOPAMINE 2 RECEPTOR; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHO CELL; CLINICAL FEATURE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG MECHANISM; DRUG RECEPTOR BINDING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT;

ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CORPUS STRIATUM; CRICETINAE; CRICETULUS; DIZOCILPINE MALEATE; DOMPERIDONE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; ISOTOPES; MEMANTINE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; TRANSFECTION;

EID: 37549005135     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20472     Document Type: Article

References (33)

1. Bickford-Wimer P, Kim M, Boyajian C, Cooper DM, Freedman R. 1990. Effects of pertussis toxin on caudate neuron electrophysiology: Studies with dopamine D1 and D2 agonists. Brain Res 533:263-267.
2. Bresink I, Benke TA, Collett VJ, Seal AJ, Parsons CG, Henley JM, Collingridge GL. 1996. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol 119:195-204.
3. Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA. 1992. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: Therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12:4427-4436.
4. Costall B, Naylor RJ. 1975. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan). Psychopharmacologia 43:53-61.
5. Fujita N, Nakahiro M, Fukuchi I, Saito K, Yoshida H. 1985. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: Evidence for coupling of Ni regulatory protein with D2-receptor. Brain Res 333:231-236.
6. George SR, Watanabe M, Di Paolo T, Falardeau P, Labrie F, Seeman P. 1985. The functional state of the dopamine receptor in the anterior pituitary is in the high-affinity form. Endocrinology 117:690-697.
7. Grigoriadis D, Seeman P. 1985. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J Neurochem 44:1925-1935.
8. Hergovich N, Singer E, Agneter E, Eichler HG, Graselli U, Simhandl C, Jilma B. 2001. Comparison of the effects of ketamine and memantine on prolactin and cortisol release in men: A randomized, double-blind, placebo-controlled trial. Neuropsychopharmacology 24:590-593.
9. Kapur S, Seeman P. 2001. Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol Psychiatry 49:954-957.
10. Kornhuber J, Quack G. 1995. Cerebrospinal fluid and serum concentrations of the N-methyl-D-aspartate (NMDA) receptor antagonist memantine in man. Neurosci Lett 195:137-139.
11. 3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 166:589-590.
12. Kornhuber J, Quack G, Danysz W, Jellinger K, Danielczyk W, Gsell W, Riederer P. 1995. Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 34:713-721.
13. Liu IS, George SR, Seeman P. 2000. The human dopamine D2 (Longer) receptor has a high-affinity state and inhibits adenylyl cyclase. Brain Res Mol Brain Res 77:281-284.
14. Login IS. 1990. Direct stimulation of pituitary prolactin release by glutamate. Life Sci 47:2269-2275.
15. Merello M, Nouzeilles MI, Cammarota A, Leiguarda R. 1999. Effect of memantine (NMDA antagonist) on Parkinson's disease: A double-blind crossover randomized study. Clin Neuropharmacol 22:273-276.
16. MRZ-9402 Report. 2004.http://www.emea.eu.int/humandocs/PDFs/EPAR/axura/ 094802en6.pdf. p 8.
17. Olianas MC, Onali P. 1987. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum. J Neurochem 48:1443-1447.
18. Pampillo M, Theas S, Duvilanski B, Seilicovich A, Lasaga M. 2002. Effect of ionotropic and metabotropic glutamate agonists and D-aspartate on prolactin release from anterior pituitary cells. Exp Clin Endocrinol Diabetes 110:138-144.
19. Parsons CG, Gruner R, Rozental J, Millar J, Lodge D. 1993. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32:1337-1350.
20. Parsons CG, Danysz W, Quack G. 1999. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist - A review of preclinical data. Neuropharmacology 38:735-767.
21. Peeters M, Maloteaux JM, Hermans E. 2003. Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatum. Neurosci Lett 343:205-209.
22. Periclou A, Ventura D, Rao N, Abramowitz W. 2006. Pharmacokinetic study of memantine in healthy and renally impaired subjects. Clin Pharmacol Ther 79:134-143.
23. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ; Memantine Study Group. 2003. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 348:1333-1341.
24. Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. 2006. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol 63:49-54.
25. Riederer P, Lange KW, Kornhuber J, Danielczyk W. 1991a. Pharmacotoxic psychosis after memantine in Parkinson's disease. Lancet 338:1022-1023.
26. Riederer P, Lange KW, Kornhuber J, Jellinger K. 1991b. Glutamate receptor antagonism: Neurotoxicity, anti-akinetic effects, and psychosis. J Neural Transm Suppl 34:203-210.
27. RxList:http://www.rxlist.com/cgi/generic3/nemda_cp.htm
28. Schneider E, Fischer PA, Clemens R, Balzereit F, Funfgeld EW, Haase HJ. 1984. Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study. Dtsch Med Wochenschr 109:987-990.
29. Seeman P, Lasaga M. 2005. Dopamine agonist action of phencyclidine. Synapse 58:275-277.
30. 3H-spiperone depend on tissue concentration: Analysis and examples. J Neurochem 43:221-235.
31. 3H]spiperone in isotonic medium: Implications for human positron emission tomography. Synapse 49:209-215.
32. Seeman P, Ko F, Tallerico T. 2005. Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 10:877-883.
33. Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A. 2006. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: A microdialysis study. Brain Res Bull 69:204-213.